News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

News|Articles|May 4, 2024

Confronting Addiction From Prevention to Recovery

Author(s)Erin O'Brien

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

sports gambling betting addiction

Gambling Addiction and Sports Betting: How Does The Addiction Start?

ByAsim A. Shah, MD

February 12th 2026

opioid epidemic psychiatry addiction

Combatting the Opioid Crisis With Evidence-Based Treatments

ByBrian J. Dawson, MD,Michael P. Frost, MD

February 9th 2026

Addressing Co-Occurring ADHD and Autism, With Lauren Kenworthy, PhD

ByLauren Kenworthy, PhD,Jessica Walters

January 30th 2026

opioids

Retention in Care: The Good, the Bad, and the Ugly

ByLiana Hamdan,Andres Avellaneda Ojeda, MD,Benjamin Li, MD

January 28th 2026

Innovative Sciences: Eric Nestler, MD, PhD Reflects on Research and Leadership in Medicine

ByEric J. Nestler, MD, PhD

January 21st 2026

Latest CME

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

OCD, Psychedelics, and Cannabinoids: New Evidence

Glutamate and GABA: The Yin and Yang of the Human Brain

From Practice to Purpose: Cultivating Leadership in Psychiatry

Lisdexamfetamine Dimesylate Oral Solution for ADHD to Be Available Mid-2026

Buntanetap for Neurodegenerative Diseases: Positive Recommendation From Data and Safety Monitoring Board